Charles Larkin - Align Technology Independent Chairman of the Board
ALGN Stock | USD 309.02 1.48 0.48% |
Chairman
Mr. Charles Raymond Larkin Jr. is Independent Chairman of the Board of the Company. Mr. Larkin has served as a director of Align since March 2004. In February 2006, Mr. Larkin was appointed as Chairman of the Board. Until 2018, he was a Principal of Group Outcome L.L.C., a merchant banking firm concentrating on medical technologies. From 2001 to 2007, he served as a part time Venture Partner at Cutlass Capital, a VC firm. Mr. Larkin was previously Chairman and Chief Executive Officer at Eunoe, Inc., a medical device company. From 1983 to March 1998, he held various executive positions with Nellcor Puritan Bennett, Inc., a medical instrumentation company, for which he served as President and Chief Executive Officer from 1989 until 1998. Mr. Larkin also held various positions of increasing responsibility at Bentley LaboratoriesAmerican Hospital Supply from 1976 to 1983. He currently serves on the board of directors of REVA Medical Inc., a medical device company developing and commercializing bioresorbable stents for the treatment of coronary artery disease. He also served on the board of directors of Heartware, Inc. prior to its acquisition by Medtronic, plc in 2016 since 2006.
Age | 69 |
Tenure | 18 years |
Address | 410 North Scottsdale Road, Tempe, AZ, United States, 85288 |
Phone | 602 742 2000 |
Web | https://www.aligntech.com |
Align Technology Management Efficiency
The company has return on total asset (ROA) of 0.0682 % which means that it generated a profit of $0.0682 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1231 %, meaning that it created $0.1231 on every $100 dollars invested by stockholders. Align Technology's management efficiency ratios could be used to measure how well Align Technology manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Align Technology's Return On Tangible Assets are very stable compared to the past year. As of the 27th of April 2024, Return On Capital Employed is likely to grow to 0.17, while Return On Equity is likely to drop 0.09. At this time, Align Technology's Intangible Assets are very stable compared to the past year. As of the 27th of April 2024, Net Tangible Assets is likely to grow to about 3.7 B, while Deferred Long Term Asset Charges is likely to drop about 52.9 M.Similar Executives
Found 13 records | CHAIRMAN Age | ||
Kevin Lobo | Stryker | 59 | |
Michael Mussallem | Edwards Lifesciences Corp | 71 | |
Lonnie Smith | Tandem Diabetes Care | 69 | |
Marilyn Nelson | Inspire Medical Systems | 81 | |
Terrance Gregg | DexCom Inc | 68 | |
Jonathan Lord | DexCom Inc | 60 | |
Dick Allen | Tandem Diabetes Care | 73 | |
Adam Elsesser | Penumbra | 62 | |
William Parfet | Stryker | 68 | |
Michael Mahoney | Boston Scientific Corp | 59 | |
Omar Ishrak | Medtronic PLC | 63 | |
Miles White | Abbott Laboratories | 65 | |
Peter Nicholas | Boston Scientific Corp | 72 |
Management Performance
Return On Equity | 0.12 | ||||
Return On Asset | 0.0682 |
Align Technology Leadership Team
Elected by the shareholders, the Align Technology's board of directors comprises two types of representatives: Align Technology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Align. The board's role is to monitor Align Technology's management team and ensure that shareholders' interests are well served. Align Technology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Align Technology's outside directors are responsible for providing unbiased perspectives on the board's policies.
Raphael Pascaud, Chief Marketing Portfolio and Bus. Devel. Officer | ||
Sreelakshmi Kolli, Vice President - Information Technology | ||
George Morrow, Independent Director | ||
David White, CFO | ||
Shirley Stacy, IR Contact Officer | ||
Joseph Hogan, CEO and President and Director | ||
Sian Roberts, Vice President and General Manager - of Canada | ||
Joseph Lacob, Independent Director | ||
Lynn Pendergrass, Vice President Managing Director - Americas Region | ||
Jennifer Erfurth, Vice President - Global Human Resources | ||
Emory Wright, Executive Operations | ||
Simon Beard, Vice President Managing Director - EMEA | ||
Kevin Dallas, Director | ||
Gregory Santora, Independent Director | ||
Zelko Relic, Vice President - Research and Development | ||
Andrea Saia, Independent Director | ||
Brad Jergenson, Vice President and General Manager - United States | ||
Raj Pudipeddi, Senior Vice President Chief Marketing Officer | ||
Susan Siegel, Independent Director | ||
Warren Thaler, Independent Director | ||
Markus Sebastian, Senior Vice President Managing Director, EMEA | ||
Raymond Larkin, Independent Chairman of the Board | ||
Vamsi Pudipeddi, Chief VP | ||
Christopher Puco, Vice President - North American Sales | ||
David Nagel, Independent Director | ||
Jennifer OlsonWilk, Executive Success | ||
John Morici, CFO Finance | ||
Anne Myong, Director | ||
Timothy Mack, VP of Marketing and Bus. Devel. | ||
Jennifer Olson, Vice President and Managing Director - Doctor Directed Consumer Channel | ||
Stuart Hockridge, Vice President - Global Human Resources | ||
Julie Tay, Vice President Managing Director - Asia Pacific | ||
Thomas Prescott, CEO and President and Director | ||
Yuval Shaked, Senior Vice President Managing Director - iTero Scanner and Services Business | ||
Charles Larkin, Independent Chairman of the Board | ||
Julie Coletti, Executive Officer | ||
Roger George, VP of Legal and Corporate Affairs, General Counsel and Corporate Secretary |
Align Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Align Technology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.12 | ||||
Return On Asset | 0.0682 | ||||
Profit Margin | 0.12 % | ||||
Operating Margin | 0.19 % | ||||
Current Valuation | 22.72 B | ||||
Shares Outstanding | 75.28 M | ||||
Shares Owned By Insiders | 6.53 % | ||||
Shares Owned By Institutions | 87.92 % | ||||
Number Of Shares Shorted | 1.38 M | ||||
Price To Earning | 29.97 X |
Pair Trading with Align Technology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Align Technology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Align Technology will appreciate offsetting losses from the drop in the long position's value.Moving together with Align Stock
0.61 | DHR | Danaher | PairCorr |
Moving against Align Stock
0.6 | GH | Guardant Health Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Align Technology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Align Technology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Align Technology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Align Technology to buy it.
The correlation of Align Technology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Align Technology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Align Technology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Align Technology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Align Technology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Align Stock, please use our How to Invest in Align Technology guide.Note that the Align Technology information on this page should be used as a complementary analysis to other Align Technology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Align Stock analysis
When running Align Technology's price analysis, check to measure Align Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Align Technology is operating at the current time. Most of Align Technology's value examination focuses on studying past and present price action to predict the probability of Align Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Align Technology's price. Additionally, you may evaluate how the addition of Align Technology to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Transaction History View history of all your transactions and understand their impact on performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Stocks Directory Find actively traded stocks across global markets |
Is Align Technology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Align Technology. If investors know Align will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Align Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.06 | Earnings Share 5.8 | Revenue Per Share 50.536 | Quarterly Revenue Growth 0.061 | Return On Assets 0.0682 |
The market value of Align Technology is measured differently than its book value, which is the value of Align that is recorded on the company's balance sheet. Investors also form their own opinion of Align Technology's value that differs from its market value or its book value, called intrinsic value, which is Align Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Align Technology's market value can be influenced by many factors that don't directly affect Align Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Align Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Align Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Align Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.